Targeting antioxidants to mitochondria: A new therapeutic direction

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 2, 2006, Pages 256-265

  Sheu, Shey Shing ^a   Nauduri, Dhananjaya ^a   Anders, M W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Mitochondria; Mitochondria membrane potential; Oxidative stress; Reactive oxygen species

Indexed keywords

2,4,6 TRIMETHYLPHENOL; ACETYLCYSTEINE CHOLINE ESTER; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CARBOXYAMIDOMETHYLATED MITOPEROXIDASE; EBSELEN; GALLIC ACID PROPYL ESTER; GLUTATHIONE CHOLINE ESTER; MITOPBN; MITOPEROXIDASE; MITOQ; MITOVIT E; N TERT BUTYL ALPHA PHENYLNITRONE; PHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; SELENIUM; SS 02; SS 19; SS 20; SS 31; TETRAPEPTIDE; TROLOX C; UBIQUINONE; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

CELL DEATH; CELL METABOLISM; CELL PROTECTION; CLINICAL TRIAL; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ACCUMULATION; DRUG MECHANISM; DRUG TARGETING; DRUG UPTAKE; FRIEDREICH ATAXIA; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; LIFE; MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW; SEPSIS; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; DRUG DESIGN; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

ATAXIA;

EID: 29344446328     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.10.007     Document Type: Review

References (63)

1. A. Tzagoloff Mitochondria 1982 Plenum Press New York
2. M.R. Abid, I.G. Schoots, K.C. Spokes, S.Q. Wu, C. Mawhinney, and W.C. Aird Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IκB/NF-κB J. Biol. Chem. 279 2004 44030 44038
3. H.J. Zhang, V.J. Drake, L. Xu, J. Hu, F.E. Domann, L.W. Oberley, and K.C. Kregel Redox regulation of adenovirus-induced AP-1 activation by overexpression of manganese-containing superoxide dismutase J. Virol. 76 2002 355 363
4. S. Li, T. Yan, J.Q. Yang, T.D. Oberley, and L.W. Oberley The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase Cancer Res. 60 2000 3927 3939
5. B.B. Warner, L. Stuart, S. Gebb, and J.R. Wispe Redox regulation of manganese superoxide dismutase Am. J. Physiol. 271 1996 L150 L158
6. J.R. Schiavone, and H.M. Hassan The role of redox in the regulation of manganese-containing superoxide dismutase biosynthesis in Escherichia coli J. Biol. Chem. 263 1988 4269 4273
7. E.A. Ross, L.C. Koo, and J.B. Moberly Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients Am. J. Kidney Dis. 30 1997 489 494
8. A. Boveris, and E. Cadenas Cellular sources and steady-state levels of reactive oxygen species L.B. Clerch D.J. Massaro Oxygen, Gene Expression, and Cellular Function 1997 Marcel Dekker New York 1 25
9. A.A. Starkov, G. Fiskum, C. Chinopoulos, B.J. Lorenzo, S.E. Browne, M.S. Patel, and M.F. Beal Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species J. Neurosci. 24 2004 7779 7788
10. M.T. Quinn, and K.A. Gauss Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases J. Leukoc. Biol. 76 2004 760 781
11. K.V. Rajagopalan Xanthine dehydrogenase and aldehyde oxidase F.P. Guengerich Biotransformation 1997 Elsevier New York 165 178
12. J.R. Cashman Monoamine oxidase and flavin-containing monooxygenases F.P. Guengerich Biotransformation 1997 Elsevier New York 69 96
13. I. Fridovich Superoxide radical and superoxide dismutases Annu. Rev. Biochem. 64 1995 97 112
14. F.A. Reubsaet, J.H. Veerkamp, S.G. Bukkens, J.M. Trijbels, and L.A. Monnens Acyl-CoA oxidase activity and peroxisomal fatty acid oxidation in rat tissues Biochim. Biophys. Acta 958 1988 434 442
15. C.C. Winterbourn, M.C. Vissers, and A.J. Kettle Myeloperoxidase Curr. Opin. Hematol. 7 2000 53 58
16. W. Dröge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
17. S. DiMauro, and E.A. Schon Mitochondrial respiratory-chain diseases N. Engl. J. Med. 348 2003 2656 2668
18. D.C. Wallace, G. Singh, M.T. Lott, J.A. Hodge, T.G. Schurr, A.M. Lezza, L.J. Elsas II, and E.K. Nikoskelainen Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy Science 242 1988 1427 1430
19. I.E. Scheffler Mitochondria 1999 Wiley-Liss New York
20. P.S. Brookes, Y. Yoon, J.L. Robotham, M.W. Anders, and S.S. Sheu Calcium, ATP, and ROS: a mitochondrial love-hate triangle Am. J. Physiol. 287 2004 C817 C833
21. D. Decaudin, I. Marzo, C. Brenner, and G. Kroemer Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy Int. J. Oncol. 12 1998 141 152
22. J.S. Modica-Napolitano, and K. Singh Mitochondria as targets for detection and treatment of cancer Expert Rev. Mol. Med. 2002 2002 1 19
23. D.W. Lamson, and M.S. Brignall Antioxidants in cancer therapy; their actions and interactions with oncologic therapies Altern. Med. Rev. 4 1999 304 329
24. M.P. Mattson Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders Neuromol. Med. 3 2003 65 94
25. I.G. Stavrovskaya, and B.S. Kristal The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death? Free Radic. Biol. Med. 38 2005 687 697
26. B. Halliwell Antioxidants: the basics-What they are and how to evaluate them Adv. Pharmacol. 38 1997 3 20
27. E.R. Miller III, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann. Intern. Med. 142 2005 37 46
28. A. Muratovska, R.N. Lightowlers, R.W. Taylor, J.A. Wilce, and M.P. Murphy Targeting large molecules to mitochondria Adv. Drug Deliv. Rev. 49 2001 189 198
29. V. Weissig Mitochondrial-targeted drug and DNA delivery Crit. Rev. Ther. Drug Carr. Syst. 20 2003 1 62
30. V. Weissig, S.V. Boddapati, G.G.M. D'Souza, and S.M. Cheng Targeting of low-molecular weight drugs to mammalian mitochondria Drug Des. Rev.-Online 1 2004 15 28
31. M.F. Ross, G.F. Kelso, F.H. Blaikie, A.M. James, H.M. Cocheme, A. Filipovska, T. Da Ros, T.R. Hurd, R.A. Smith, and M.P. Murphy Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology Biochemistry (Moscow) 70 2005 222 230
32. R.A. Smith, C.M. Porteous, C.V. Coulter, and M.P. Murphy Selective targeting of an antioxidant to mitochondria Eur. J. Biochem. 263 1999 709 716
33. G. Hughes, M.P. Murphy, and E.C. Ledgerwood Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor κB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants Biochem. J. 389 2005 83 89
34. V. Calabrese, R. Lodi, C. Tonon, V. D'Agata, M. Sapienza, G. Scapagnini, A. Mangiameli, G. Pennisi, A.M. Stella, and D.A. Butterfield Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia J. Neurol. Sci. 233 2005 145 162
35. P.E. Hart, R. Lodi, B. Rajagopalan, J.L. Bradley, J.G. Crilley, C. Turner, A.M. Blamire, D. Manners, P. Styles, A.H. Schapira, and J.M. Cooper Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up Arch. Neurol. 62 2005 621 626
36. M.L. Jauslin, T. Meier, R.A. Smith, and M.P. Murphy Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants FASEB J. 17 2003 1972 1974
37. A. Dhanasekaran, S. Kotamraju, S.V. Kalivendi, T. Matsunaga, T. Shang, A. Keszler, J. Joseph, and B. Kalyanaraman Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis J. Biol. Chem. 279 2004 37575 37587
38. G.F. Kelso, C.M. Porteous, C.V. Coulter, G. Hughes, W.K. Porteous, E.C. Ledgerwood, R.A.J. Smith, and M.P. Murphy Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties J. Biol. Chem. 276 2001 4588 4596
39. J. Asin-Cayuela, A.R. Manas, A.M. James, R.A. Smith, and M.P. Murphy Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant FEBS Lett. 571 2004 9 16
40. A.M. James, H.M. Cocheme, R.A. Smith, and M.P. Murphy Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools J. Biol. Chem. 280 2005 21295 21312
41. K.S. Echtay, M.P. Murphy, R.A. Smith, D.A. Talbot, and M.D. Brand Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants J. Biol. Chem. 277 2002 47129 47135
42. G. Saretzki, M.P. Murphy, and T. von Zglinicki MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress Aging Cell 2 2003 141 143
43. V.J. Adlam, J.C. Harrison, C.M. Porteous, A.M. James, R.A. Smith, M.P. Murphy, and I.A. Sammut Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J. 19 2005 1088 1095
44. G.F. Kelso, C.M. Porteous, G. Hughes, E.C. Ledgerwood, A.M. Gane, R.A. Smith, and M.P. Murphy Prevention of mitochondrial oxidative damage using targeted antioxidants Ann. N. Y. Acad. Sci. 959 2002 263 274
45. R.A. Smith, C.M. Porteous, A.M. Gane, and M.P. Murphy Delivery of bioactive molecules to mitochondria in vivo Proc. Natl. Acad. Sci. U. S. A. 100 2003 5407 5412
46. L.R. Barclay, and M.R. Vinqvist Do spin traps also act as classical chain-breaking antioxidants? A quantitative kinetic study of phenyl tert-butylnitrone (PBN) in solution and in liposomes Free Radic. Biol. Med. 28 2000 1079 1090
47. Y. Kotake Pharmacologic properties of phenyl N-tert-butylnitrone Antioxid. Redox Signal. 1 1999 481 499
48. R.A. Floyd Antioxidants, oxidative stress, and degenerative neurological disorders Proc. Soc. Exp. Biol. Med. 222 1999 236 245
49. M.P. Murphy, K.S. Echtay, F.H. Blaikie, J. Asin-Cayuela, H.M. Cocheme, K. Green, J.A. Buckingham, E.R. Taylor, F. Hurrell, G. Hughes, S. Miwa, C.E. Cooper, D.A. Svistunenko, R.A. Smith, and M.D. Brand Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from α-phenyl-N-tert-butylnitrone J. Biol. Chem. 278 2003 48534 48545
50. G. Mugesh, W.W. du Mont, and H. Sies Chemistry of biologically important synthetic organoselenium compounds Chem. Rev. 101 2001 2125 2179
51. A. Filipovska, G.F. Kelso, S.E. Brown, S.M. Beer, R.A. Smith, and M.P. Murphy Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic: insights into the interaction of ebselen with mitochondria J. Biol. Chem. 280 2005 24113 24126
52. K. Zhao, G.M. Zhao, D. Wu, Y. Soong, A.V. Birk, P.W. Schiller, and H.H. Szeto Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J. Biol. Chem. 279 2004 34682 34690
53. J.S. Wright, D.J. Carpenter, D.J. McKay, and K.U. Ingold Theoretical calculation of substituent effects on the OH bond strength of phenolic antioxidants related to vitamin E J. Am. Chem. Soc. 119 1997 4245 4252
54. P.W. Schiller, T.M.-D. Nguyen, I. Berezowska, S. Dupuis, G. Weltrowska, N.N. Chung, and C. Lemieux Synthesis and in vitro opioid activity profiles of DALDA analogues Eur. J. Med. Chem. 35 2000 895 901
55. 1]DALDA and DAMGO in binding and G protein activation at μ, δ, and κ opioid receptors J. Pharmacol. Exp. Ther. 307 2003 947 954
56. + net charge opioid tetrapeptide J. Pharmacol. Exp. Ther. 304 2003 425 432
57. N. Taniguchi, T. Higashi, Y. Sakamoto, and A. Meister Glutathione centennial Molecular Perspectives and Clinical Implications 1989 Academic Press San Diego
58. O.W. Griffith, and A. Meister Origin and turnover of mitochondrial glutathione Proc. Natl. Acad. Sci. U. S. A. 82 1985 4668 4672
59. Z. Chen, and L.H. Lash Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers J. Pharmacol. Exp. Ther. 285 1998 608 618
60. Z. Chen, D.A. Putt, and L.H. Lash Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport Arch. Biochem. Biophys. 373 2000 193 202
61. M.J. Meredith, and D.J. Reed Status of the mitochondrial pool of glutathione in the isolated hepatocyte J. Biol. Chem. 257 1982 3747 3753
62. M.J. Meredith, and D.J. Reed Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Biochem. Pharmacol. 32 1982 1383 1388
63. X. Shan, D.P. Jones, M. Hashmi, and M.W. Anders Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death Chem. Res. Toxicol. 6 1993 75 81